26
Arginine Deiminase (ADI), Pseudomonas Aeruginosa Recombinant | P1411
- SKU:
- 26-P1411-GEN
- Availability:
- Usually shipped in 5 working days
Description
Arginine deiminase (ADI) is a potential anti-tumor biologics for the treatment of arginine-auxotrophic tumors, such as hepatocellular carcinomas and melanomas. ADI hydrolyzes arginine to citrulline and ammonia.
P1411 | Arginine Deiminase (ADI), Pseudomonas Aeruginosa Recombinant DataSheet
Biomolecule/Target :
Synonyms: Arginine dihydrolase, AD, arcA
Alternates names: Arginine dihydrolase, AD, arcA
Taglines: A potential anti-tumor biologics
NCBI Gene ID #: 881801
NCBI Gene Symbol: arcA
Gene Source: Pseudomonas Aeruginosa
Accession #: P13981
Recombinant: True
Source: E.coli
Purity by SDS-PAGE: >95%
Assay: SDS-PAGE.
Purity:
Assay #2:
Endotoxin Level:
Activity (Specifications/test method): This enzyme has a specific activity of ≥ 100 mU/mg based on its conversion of arginine to citrulline, which can be detected fluorometrically at Ex/Em=535/595 using ’s Methionine Assay Kit (Cat. No. K442).
Biological activity:
Results: 100 mU/mg
Binding Capacity:
Unit Definition: One unit is defined as the amount of enzyme that will hydrolyze 1.0 umole of arginine to citrulline per minute at pH 7.4 and 25 ÌŠC.
Molecular Weight: 46.3 kDa with N-terminal 6X-His tag
Concentration:
Appearance: Sterile Filtered colorless solution
Physical form description: Liquid
Reconstitution Instructions:
Amino acid sequence: aa 1-418
Handling: Centrifuge the vial prior to opening.
Usage:
Additional Information
Storage Temperature: |
-20°C |
Shipping: |
Gel Pack |
Shelf Life: |
12 months |